Medication strategies in first onset schizophrenia (Mesifos).

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON24373

Enrollment

131

Registered

2005-09-12

Start date

2001-08-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-affective psychosis (schizophrenia and related disorders DSM-IV).

Interventions

Maintenance treatment was carried out according to the guidelines of the APA. This entailed the preferred use of second-generation antipsychotics in low dose. In targeted treatment the dose was gradu

Eligibility

Inclusion criteria

Inclusion criteria: 1. Suffering from a first episode of psychosis; 2. Being 18- 45 years of age; 3. Being treatment naïve; 4. Responding to medication (remission of positive symptoms) within 6 months and remaining stable for another 6 months.

Exclusion criteria

Exclusion criteria: No remission or relapse within 6 months.

Design outcomes

Primary

Measure	Time frame
Quality of life.	—

Secondary

Measure	Time frame
1. Symptomatology; 2. Relapse; 3. Side effects; 4. Social functioning; 5. Burden on the family.	—

Contacts

Public ContactD. Wiersma

University Medical Center Groningen (UMCG), Department of Psychiatry, P.O. Box 30001

d.wiersma@med.umcg.nl+31 (0)50 3613839

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)